REVIEW Quisinostat (JNJ-26481585) is a novel second-generation HDAC inhibitor of HDAC1,2,4,10 and 11. Its highest potency is against HDAC1 with an IC50 of 0.11 nM. It has only modest potency against HDACs 2, 4, 10, and 11 (IC50 ranging from 0.33 nM to 0.64 nM). It has low activity against HDACs 3, 5, 8, and 9 and its lowest potency is against HDACs 6 and 7.
All products are stocked and shipped from the SF Bay, California, USA via FedEx, UPS or DHL.
All batches backed with full quality assurance.
??
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.